Cargando…
Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering?
Immune checkpoint mechanisms are important molecular cell systems that maintain tolerance toward autoantigens in order to prevent immunity-mediated accidental damage. It is well known that cancer cells may exploit these molecular and cellular mechanisms to escape recognition and elimination by immun...
Autores principales: | Zanello, Andrea, Bortolotti, Massimo, Maiello, Stefania, Bolognesi, Andrea, Polito, Letizia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424723/ https://www.ncbi.nlm.nih.gov/pubmed/36052121 http://dx.doi.org/10.3389/fphar.2022.972046 |
Ejemplares similares
-
Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives
por: Mercatelli, Daniele, et al.
Publicado: (2018) -
Kirkiin: A New Toxic Type 2 Ribosome-Inactivating Protein from the Caudex of Adenia kirkii
por: Bortolotti, Massimo, et al.
Publicado: (2021) -
Ribosome-Inactivating Proteins from Plants: A Historical Overview
por: Bolognesi, Andrea, et al.
Publicado: (2016) -
Plants Producing Ribosome-Inactivating Proteins in Traditional Medicine
por: Polito, Letizia, et al.
Publicado: (2016) -
Editorial: Toxic Plant Proteins as Experimental Drugs for Human Pathologies
por: Polito, Letizia, et al.
Publicado: (2021)